Harvard Bioscience (HBIO) EBT Margin Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 803.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 146.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -1,042.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 773.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -388.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -1,500.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -1,195.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1,240.00 |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -545.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -545.00 |
| Mar 31, 2026 | -1,996.00 |
| Dec 31, 2025 | -1,036.00 |
| Sep 30, 2025 | 1,191.00 |
| Jun 30, 2025 | -2,273.00 |
| Mar 31, 2025 | -20,889.00 |
| Dec 31, 2024 | -102.00 |
| Sep 30, 2024 | -2,059.00 |
| Jun 30, 2024 | -1,204.00 |
| Mar 31, 2024 | -1,576.00 |
| Dec 31, 2023 | -215.00 |
| Sep 30, 2023 | 367.00 |
| Jun 30, 2023 | -357.00 |
| Mar 31, 2023 | 2,279.00 |
| Dec 31, 2022 | -345.00 |
| Sep 30, 2022 | -767.00 |
| Jun 30, 2022 | 1,554.00 |
| Mar 31, 2022 | -1,803.00 |
| Dec 31, 2021 | 329.00 |
| Sep 30, 2021 | 332.00 |